NLS Pharmaceutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NLSP and other ETFs, options, and stocks.About NLSP
NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. Its product portfolio includes Quilience, a treatment for excessive daytime sleepiness and cataplexy associated with narcolepsy; and Nolazol, a treatment for attention deficit hyperactivity disorder.
CEOAlexander C. Zwyer
CEOAlexander C. Zwyer
Employees3
Employees3
HeadquartersZurich, Zurich
HeadquartersZurich, Zurich
Founded2015
Founded2015
Employees3
Employees3
NLSP Key Statistics
Market cap9.17M
Market cap9.17M
Price-Earnings ratio-0.98
Price-Earnings ratio-0.98
Dividend yield—
Dividend yield—
Average volume405.55K
Average volume405.55K
High today$2.70
High today$2.70
Low today$2.02
Low today$2.02
Open price$2.34
Open price$2.34
Volume448.40K
Volume448.40K
52 Week high$15.59
52 Week high$15.59
52 Week low$1.30
52 Week low$1.30
People also own
Based on the portfolios of people who own NLSP. This list is generated using Robinhood data, and it’s not a recommendation.